Quick Answer
ANI PHARMACEUTICALS INC reported Total Assets of $1.44 billion for fiscal year 2025.
ANI PHARMACEUTICALS INC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.44B | +12.1% |
| 2024 | $1.28B | +42.0% |
| 2023 | $904.42M | +19.0% |
| 2022 | $760.09M | -1.5% |
| 2021 | $771.60M | +67.3% |
| 2020 | $461.19M | +1.0% |
| 2019 | $456.79M | +6.1% |
| 2018 | $430.60M | +4.5% |
| 2017 | $412.14M | +27.7% |
| 2016 | $322.86M | +13.2% |
| 2015 | $285.26M | +9.9% |
| 2014 | $259.56M | +483.3% |
| 2013 | $44.50M | +223.7% |
| 2012 | $13.75M | -78.0% |
| 2011 | $62.38M | +39.3% |
| 2010 | $44.77M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.41B | +9.4% | +4.9% |
| June 30, 2025 | $1.34B | +45.9% | +3.9% |
| March 31, 2025 | $1.29B | +41.3% | +0.7% |
| December 31, 2024 | $1.28B | +41.9% | -0.3% |
| September 30, 2024 | $1.29B | +44.7% | +39.8% |
| June 30, 2024 | $920.75M | +7.1% | +0.7% |
| March 31, 2024 | $914.52M | +19.5% | +1.1% |
| December 31, 2023 | $904.42M | +19.0% | +1.6% |
- ANI PHARMACEUTICALS INC showed an increase of +12.1% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, ANI PHARMACEUTICALS INC’s total assets has grown by 3117.5% (from $44.77 million to $1.44 billion).
- The most recent figure is from ANI PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: